NormaLeah Ovarian Cancer Initiative – Trademark Portfolio
Entity Type: 03
NormaLeah Ovarian Cancer Initiative holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 41 (Education & Entertainment) — 1 filings in this category. The portfolio also extends into Class 36 (Insurance & Financial) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include BEAT THE BIG O. The owner is based in Rock Island, IL.
1612 2nd Avenue
Rock Island, IL 61201
Showing of trademarks Trademarks
Trademark Classifications
NormaLeah Ovarian Cancer Initiative's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Education; providing of training; entertainment; sporting and cultural activities
Insurance; financial affairs; monetary affairs; real estate affairs
Frequently Asked Questions
How many trademarks does NormaLeah Ovarian Cancer Initiative have?
NormaLeah Ovarian Cancer Initiative has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 abandoned.
What trademark classes does NormaLeah Ovarian Cancer Initiative file in?
NormaLeah Ovarian Cancer Initiative files trademarks across 2 Nice Classification classes. The most active classes are Class 41 (Education & Entertainment), Class 36 (Insurance & Financial). Class 41 covers education; providing of training; entertainment; sporting and cultural activities.
What are NormaLeah Ovarian Cancer Initiative's most well-known trademarks?
NormaLeah Ovarian Cancer Initiative's registered trademark portfolio includes well-known marks such as BEAT THE BIG O. These are among 1 currently registered trademark in the portfolio.
What is NormaLeah Ovarian Cancer Initiative's trademark registration success rate?
NormaLeah Ovarian Cancer Initiative has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.